Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 190 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cellsOoi, J.; Petersen, J.; Tan, Y.; Huynh, M.; Willett, Z.; Ramarathinam, S.; Eggenhuizen, P.; Loh, K.; Watson, K.; Gan, P.; Alikhan, M.; Dudek, N.; Handel, A.; Hudson, B.; Fugger, L.; Power, D.; Holt, S.; Coates, P.; Gregersen, J.; Purcell, A.; et al.
2017Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerPonnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
2017Antenatal suppression of il-1 protects against inflammation-induced fetal injury and improves neonatal and developmental outcomes in miceNadeau-Vallée, M.; Chin, P.; Belarbi, L.; Brien, M.; Pundir, S.; Berryer, M.; Beaudry-Richard, A.; Madaan, A.; Sharkey, D.; Lupien-Meilleur, A.; Hou, X.; Quiniou, C.; Beaulac, A.; Boufaied, I.; Boudreault, A.; Carbonaro, A.; Doan, N.; Joyal, J.; Lubell, W.; Olson, D.; et al.
2012Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressorMori, S.; Bernardi, R.; Laurent, A.; Resnati, M.; Crippa, A.; Gabrieli, A.; Keough, R.; Gonda, T.; Blasi, F.; Plow, E.
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2016Polyphenols and glycémie controlKim, Y.A.; Keogh, J.B.; Clifton, P.M.
2015Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) AntagonistsSelfridge, B.R.; Wang, X.; Zhang, Y.; Yin, H.; Grace, P.M.; Watkins, L.R.; Jacobson, A.E.; Rice, K.C.
2015The therapeutic potential of interleukin-10 in neuroimmune diseasesKwilasz, A.J.; Grace, P.M.; Serbedzija, P.; Maier, S.F.; Watkins, L.R.
2014Incretins and the intensivist: what are they and what does an intensivist need to know about them?Plummer, M.; Chapman, M.; Horowitz, M.; Deane, A.
2014Aberrant GDF9 expression and activation are associated with common human ovarian disordersSimpson, C.; Robertson, D.; Al-Musawi, S.; Heath, D.; McNatty, K.; Ritter, L.; Mottershead, D.; Gilchrist, R.; Harrison, C.; Stanton, P.